# Deltagen Inc. (DGEN)

> Source: Nexqual · https://nexqual.com/DGEN · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Deltagen Inc. (DGEN), nexqual.com/DGEN" · informational, not investment advice.

**Price:** USD 0 (+0.00% on the day) · last close of Oct 22, 2026; US market after hours, not a live price. Prev close 0 · day 0–0 · 52w 0–0 · market cap $2.7M · PNK

## Key facts
- Analysts: None.
- Total return with dividends: 1Y +0.0% vs S&P 500 +13.4%; 5Y +0.0% vs S&P 500 +76.9%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +0.0% | +0.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +0.0% | +0.0% |
| Volatility (annualized) | 0.0% | 0.0% |
| Max drawdown | +0.0% (→) | +0.0% (→) |

## Peers (Medical Instruments & Supplies)
KMTS (Kestra Medical Technologies, Lt) USD 28.76 +1.55% · XRAY (DENTSPLY SIRONA Inc.) USD 9.43 -0.74% · LMAT (LeMaitre Vascular, Inc.) USD 84.45 -1.03% · ATRC (AtriCure, Inc.) USD 58.97 -0.56% · WRBY (Warby Parker Inc.) USD 25.91 +0.93% · PLSE (Pulse Biosciences, Inc) USD 53.02 +0.65%

## More
Full page: https://nexqual.com/DGEN · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |